Indications
Indication and Clinical use
Teriparatide (rDNA origin) injection is indicated
- For the treatment of postmenopausal women with severe Osteoporosis who are at high risk of fracture or who have failed or are intolerant to previous Osteoporosis therapy
- To increase bone mass in men with primary or hypogonadal severe osteoporosis who have failed or are intolerant to previous Osteoporosis therapy. The effects of Teriparatide on risk for fracture in men have not been demonstrated.
- For the treatment of Osteoporosis associated with sustained systemic glucocorticoid therapy in men and women who are at increased risk for fracture
